However few of these variants (COMT, CYP1B1, GSTP1, MnSOD, MTHFR) have been shown to contribute to breast cancer risk individually except when these polymorphisms are combined [237], or in the presence of relevant environmental chemical and lifestyle exposures [238,239]. The gene discussed is MTHFR; the disease is breast carcinoma.